4.7 Article

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis et al.

NATURE (2010)

Review Oncology

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Jeffrey A. Engelman

NATURE REVIEWS CANCER (2009)

Article Multidisciplinary Sciences

Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis

Shidong Jia et al.

NATURE (2008)

Article Biochemistry & Molecular Biology

A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling

Zachary A. Knight et al.

Article Biochemistry & Molecular Biology

A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling

Zachary A. Knight et al.

Review Oncology

Microenvironmental interactions and survival of CLL B-cells

IM Pedersen et al.

LEUKEMIA & LYMPHOMA (2004)

Article Biochemistry & Molecular Biology

Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex

ST Jou et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)